SCHEMBL14865764

SCHEMBL14865764

CCCOCCOCC(O)CSCC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.41
PLA2G4B P0C869 2/20 0.39
MAPT P10636 3/20 0.37
GMNN O75496 1/20 0.37
TP53 P04637 1/20 0.37
POLB P06746 1/20 0.37
THRB P10828 1/20 0.37
CYP2C9 P11712 1/20 0.37
BLM P54132 1/20 0.37
TDP1 Q9NUW8 1/20 0.36
CYP2D6 P10635 1/20 0.35
HIF1A Q16665 1/20 0.35
USP2 O75604 2/20 0.35
HTT P42858 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14865692 0.84 PLA2G4B (0.55) HSD17B10PLA2G4BMAPTTDP1USP2
SCHEMBL14865763 0.83 CYP1A2 (0.41) HSD17B10PLA2G4BMAPTCYP2C9TDP1
SCHEMBL18807000 0.81 LPAR5 (0.38) HSD17B10PLA2G4BMAPTGMNNTP53
SCHEMBL17383996 0.79 USP2 (0.38) PLA2G4BCYP2D6HIF1AUSP2HTT
SCHEMBL14865723 0.76 HSD17B10 (0.44) HSD17B10PLA2G4BMAPTTHRBTDP1
SCHEMBL14865767 0.75 HSD17B10 (0.44) HSD17B10PLA2G4BMAPTTDP1USP2
SCHEMBL14865721 0.75 PLA2G4B (0.41) HSD17B10PLA2G4BMAPTTDP1USP2
SCHEMBL17933338 0.74 HSD17B10 (0.50) HSD17B10PLA2G4BMAPTTDP1USP2
SCHEMBL14865731 0.73 USP2 (0.50) HSD17B10PLA2G4BMAPTGMNNTP53
SCHEMBL14865730 0.72 PLA2G4B (0.50) PLA2G4BMAPTUSP2HTTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530559-B2 Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites DIC CORPORATION (JP) 2013-09-10 US disclosed
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES DIC CORPORATION (JP) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130095320-A1 COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES AOC3, AOC2, CORO1C HSD17B10 2100/4885PLA2G4B 4671/4885MAPT 1984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.